Catalyst Wire Dossier Catalyst Wire Dossier

Vamorolone

vamorolone · ReveraGen BioPharma, Inc.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Vamorolone, covering 2019-01-02 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy [Phase 4]

See pricing